Lataa...
Carboxyamidotriazole exerts anti-inflammatory activity in lipopolysaccharide-induced RAW264.7 macrophages by inhibiting NF-κB and MAPKs pathways
Carboxyamidotriazole (CAI), originally developed as a non-cytotoxic anti-cancer drug, was shown to have anti-inflammatory activity according to recent studies in a number of animal models of inflammation. However, its mechanism of action has not been characterized. Therefore, the present study was p...
Tallennettuna:
| Julkaisussa: | Exp Ther Med |
|---|---|
| Päätekijät: | , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
D.A. Spandidos
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7388320/ https://ncbi.nlm.nih.gov/pubmed/32742379 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2020.8889 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|